Neurinnov
Neurinnov is a pioneering company developing implantable neurostimulation solutions to address critical unmet medical needs, especially for patients with severe paralysis such as tetraplegia. With a strong research background from INRIA and the University of Montpellier, the company focuses on restoring motor functions through advanced, selective neural stimulation technology. Their mission is to improve patient autonomy and quality of life by creating innovative, effective, and safe neurostimulation devices.
Industries
Nr. of Employees
small (1-50)
Neurinnov
73, allée Kleber, 34000 MONTPELLIER – Occitanie – France
Products
Implantable selective neurostimulator (prototype/early clinical device)
An implantable neurostimulation system that combines an embedded ASIC, multi-contact cuff electrodes, external controller with wireless power/data transfer, and patient-facing control software to enable selective muscle activation for restoration of hand grasp in patients with high spinal cord injury.
Implantable selective neurostimulator (prototype/early clinical device)
An implantable neurostimulation system that combines an embedded ASIC, multi-contact cuff electrodes, external controller with wireless power/data transfer, and patient-facing control software to enable selective muscle activation for restoration of hand grasp in patients with high spinal cord injury.
Services
Partnering with academic labs, hospitals and industry to co-develop selective neurostimulation technologies and to participate in EU-funded research projects.
Design and execution support for early-stage human feasibility studies and preclinical experiments combining stimulation with biomaterials/pharmacology in animal models.
Engagement with investors and potential licensees to support commercialization, IP licensing and manufacturing scale-up.
Partnering with academic labs, hospitals and industry to co-develop selective neurostimulation technologies and to participate in EU-funded research projects.
Design and execution support for early-stage human feasibility studies and preclinical experiments combining stimulation with biomaterials/pharmacology in animal models.
Engagement with investors and potential licensees to support commercialization, IP licensing and manufacturing scale-up.
Expertise Areas
- Selective neurostimulation
- Implantable active medical device development
- ASIC development for medical implants
- Multi-contact electrode design and peripheral nerve interfaces
Key Technologies
- Application-specific integrated circuits (ASICs) for neural stimulation
- Multi-contact epineural cuff electrodes
- 3D current steering/current shaping
- Complex programmable stimulation waveforms
News & Updates
Neurinnov was selected as a laureate of Boost Invest MedVallée Montpellier, receiving the special “Waouh” award for breakthrough innovation with high potential.
Neurinnov announced its participation in the DREIMS European project aimed at developing a multi-contact neural stimulator for treating spinal cord injuries.
Neurinnov announced its involvement in the AI-Hand Project, which aims to restore hand functions in patients with low tetraplegia through selective neural electrical stimulation.
Neurinnov was awarded the €30K Grand Prize at the Les Inn’Ovations awards for its innovative neurostimulation device that restores hand function in tetraplegic patients.
Neurinnov published positive results from clinical studies demonstrating the ability to restore hand control in patients with high spinal cord injuries.
Technical results obtained with the full device on the first two patients, demonstrating selectivity and personalized stimulation.
Neurinnov was selected as a laureate of Boost Invest MedVallée Montpellier, receiving the special “Waouh” award for breakthrough innovation with high potential.
Neurinnov announced its participation in the DREIMS European project aimed at developing a multi-contact neural stimulator for treating spinal cord injuries.
Neurinnov announced its involvement in the AI-Hand Project, which aims to restore hand functions in patients with low tetraplegia through selective neural electrical stimulation.
Neurinnov was awarded the €30K Grand Prize at the Les Inn’Ovations awards for its innovative neurostimulation device that restores hand function in tetraplegic patients.
Neurinnov published positive results from clinical studies demonstrating the ability to restore hand control in patients with high spinal cord injuries.
Technical results obtained with the full device on the first two patients, demonstrating selectivity and personalized stimulation.